Argo Biopharmaceutical to present BW-20805 Phase II interim data at AAAAI 2026 Annual Meeting

Novartis to build new radioligand therapy site in Texas

GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline

Epredia signs EU distribution deal with Mindpeak for AI pathology software

Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA

Astellas Pharma signs global strategic collaboration with Vir Biotechnology

Illumina sets out 18-Month NovaSeq X roadmap to boost sequencing performance and scale

Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH

Formosa Pharmaceuticals signs licensing deal with Arrotex for APP13007 in Australia and New Zealand

Gilead to acquire Arcellx to gain full control of anito-cel

AbbVie's VENCLEXTA (venetoclax) and acalabrutinib combination receives US FDA approval to treat CLL

CStone Pharmaceuticals' sugemalimab granted new indication by UK MHRA

FDA accepts Genentech application for giredestrant combination in ESR1-mutated advanced breast cancer

Reacta Healthcare names new chair of board

Lario Therapeutics awarded USD2.4m in grants for neuronal calcium channel research